As of 2026-03-29, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is -12.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is 244.19 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is -19.15 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 11.0x | 9.7x |
| Forward P/E multiples | 8.1x - 10.5x | 9.7x |
| Fair Price | (2.46) - (3.00) | (2.82) |
| Upside | -187.4% - -206.6% | -200.2% |
| Date | EV/EBITDA |
| 2026-03-23 | -15.57 |
| 2026-03-20 | -15.20 |
| 2026-03-19 | -15.37 |
| 2026-03-18 | -15.85 |
| 2026-03-17 | -16.02 |
| 2026-03-16 | -15.93 |
| 2026-03-13 | -16.15 |
| 2026-03-12 | -16.32 |
| 2026-03-11 | -17.10 |
| 2026-03-10 | -17.47 |
| 2026-03-09 | -16.63 |
| 2026-03-06 | -16.19 |
| 2026-03-05 | -16.84 |
| 2026-03-04 | -16.84 |
| 2026-03-03 | -16.41 |
| 2026-03-02 | -17.23 |
| 2026-02-27 | -17.43 |
| 2026-02-26 | -17.71 |
| 2026-02-25 | -18.23 |
| 2026-02-24 | -17.45 |
| 2026-02-23 | -17.43 |
| 2026-02-20 | -17.41 |
| 2026-02-19 | -17.23 |
| 2026-02-18 | -17.62 |
| 2026-02-17 | -16.78 |
| 2026-02-16 | -16.52 |
| 2026-02-13 | -16.82 |
| 2026-02-12 | -15.93 |
| 2026-02-11 | -16.13 |
| 2026-02-10 | -17.13 |
| 2026-02-09 | -16.32 |
| 2026-02-06 | -15.96 |
| 2026-02-05 | -16.17 |
| 2026-02-04 | -16.04 |
| 2026-02-03 | -16.37 |
| 2026-02-02 | -16.74 |
| 2026-01-30 | -16.58 |
| 2026-01-29 | -16.65 |
| 2026-01-28 | -17.32 |
| 2026-01-27 | -17.91 |
| 2026-01-26 | -17.62 |
| 2026-01-23 | -18.69 |
| 2026-01-22 | -18.32 |
| 2026-01-21 | -17.52 |
| 2026-01-20 | -17.65 |
| 2026-01-19 | -17.95 |
| 2026-01-16 | -17.62 |
| 2026-01-15 | -18.01 |
| 2026-01-14 | -17.84 |
| 2026-01-13 | -18.14 |